Connection

William Hrushesky to Mice

Back to Details
This is a "connection" page, showing publications William Hrushesky has written about Mice.
William Hrushesky
Connection Strength
0.721
Mice
  1. Circadian transcription profile of mouse breast cancer under light-dark and dark-dark conditions. Cancer Genomics Proteomics. 2010 Nov-Dec; 7(6):311-22.
    View in: PubMed
    Score: 0.039
  2. Clock genes and cancer. Integr Cancer Ther. 2009 Dec; 8(4):303-8.
    View in: PubMed
    Score: 0.036
  3. Circadian time-dependent tumor suppressor function of period genes. Integr Cancer Ther. 2009 Dec; 8(4):309-16.
    View in: PubMed
    Score: 0.036
  4. Discovery of candidate genes and pathways that may help explain fertility cycle stage dependent post-resection breast cancer outcome. Breast Cancer Res Treat. 2009 Nov; 118(2):345-59.
    View in: PubMed
    Score: 0.036
  5. The circadian clock gene Per1 suppresses cancer cell proliferation and tumor growth at specific times of day. Chronobiol Int. 2009 Oct; 26(7):1323-39.
    View in: PubMed
    Score: 0.036
  6. Beta-catenin induces beta-TrCP-mediated PER2 degradation altering circadian clock gene expression in intestinal mucosa of ApcMin/+ mice. J Biochem. 2009 Mar; 145(3):289-97.
    View in: PubMed
    Score: 0.034
  7. Period 2 mutation accelerates ApcMin/+ tumorigenesis. Mol Cancer Res. 2008 Nov; 6(11):1786-93.
    View in: PubMed
    Score: 0.034
  8. Down regulation of circadian clock gene Period 2 accelerates breast cancer growth by altering its daily growth rhythm. Breast Cancer Res Treat. 2009 Sep; 117(2):423-31.
    View in: PubMed
    Score: 0.033
  9. Seasonal modulation of post-resection breast cancer metastasis. Breast Cancer Res Treat. 2008 Sep; 111(2):219-28.
    View in: PubMed
    Score: 0.031
  10. Circadian clock coordinates cancer cell cycle progression, thymidylate synthase, and 5-fluorouracil therapeutic index. Mol Cancer Ther. 2006 Aug; 5(8):2023-33.
    View in: PubMed
    Score: 0.029
  11. Developmental abnormalities in multiple proliferative tissues of Apc(Min/+) mice. Int J Exp Pathol. 2006 Jun; 87(3):227-36.
    View in: PubMed
    Score: 0.028
  12. Cancer growth and spread are saltatory and phase-locked to the reproductive cycle through mediators of angiogenesis. Mol Cancer Ther. 2005 Jul; 4(7):1065-75.
    View in: PubMed
    Score: 0.027
  13. Daily coordination of cancer growth and circadian clock gene expression. Breast Cancer Res Treat. 2005 May; 91(1):47-60.
    View in: PubMed
    Score: 0.026
  14. Sex cycle modulates cancer growth. Breast Cancer Res Treat. 2005 May; 91(1):95-102.
    View in: PubMed
    Score: 0.026
  15. Fertility cycle influence on surgical breast cancer cure. Breast Cancer Res Treat. 2002 Sep; 75(1):65-72.
    View in: PubMed
    Score: 0.022
  16. Circadian coordination of cancer growth and metastatic spread. Int J Cancer. 1999 Oct 29; 83(3):365-73.
    View in: PubMed
    Score: 0.018
  17. Fertility maintenance and 5-fluorouracil timing within the mammalian fertility cycle. Reprod Toxicol. 1999 Sep-Oct; 13(5):413-20.
    View in: PubMed
    Score: 0.018
  18. Square pegs in round holes. Int J Cancer. 1995 Sep 04; 62(5):651-2.
    View in: PubMed
    Score: 0.014
  19. Circadian dynamics of tumor necrosis factor alpha (cachectin) lethality. J Exp Med. 1994 Sep 01; 180(3):1059-65.
    View in: PubMed
    Score: 0.013
  20. Circadian cancer pharmacodynamics. Ann Ist Super Sanita. 1993; 29(4):705-10.
    View in: PubMed
    Score: 0.011
  21. Prohibitin as an oxidative stress biomarker in the eye. Int J Biol Macromol. 2010 Dec 01; 47(5):685-90.
    View in: PubMed
    Score: 0.010
  22. Cleavage of the retinal pigment epithelium-specific protein RPE65 under oxidative stress. Int J Biol Macromol. 2010 Aug 01; 47(2):104-8.
    View in: PubMed
    Score: 0.009
  23. Melatonin reprogrammes proteomic profile in light-exposed retina in vivo. Int J Biol Macromol. 2010 Aug 01; 47(2):255-60.
    View in: PubMed
    Score: 0.009
  24. Menstrual influence on surgical cure of breast cancer. Lancet. 1990 Apr 21; 335(8695):984.
    View in: PubMed
    Score: 0.009
  25. Cancer chronotherapy: a drug delivery challenge. Prog Clin Biol Res. 1990; 341A:1-10.
    View in: PubMed
    Score: 0.009
  26. Neuroprotective role of erythropoietin by antiapoptosis in the retina. J Neurosci Res. 2009 Aug 01; 87(10):2365-74.
    View in: PubMed
    Score: 0.009
  27. Circadian rhythm and seasonal dependence in the toxicological response of mice to epirubicin. Invest New Drugs. 1988 Dec; 6(4):273-83.
    View in: PubMed
    Score: 0.008
  28. Natural killer cell activity: age, estrous- and circadian-stage dependence and inverse correlation with metastatic potential. J Natl Cancer Inst. 1988 Oct 05; 80(15):1232-7.
    View in: PubMed
    Score: 0.008
  29. Splenocyte natural killer cell activity and metastatic potential are inversely dependent on estrous stage. Surgery. 1988 Aug; 104(2):398-403.
    View in: PubMed
    Score: 0.008
  30. Estrous influence on surgical cure of a mouse breast cancer. J Exp Med. 1988 Jul 01; 168(1):73-83.
    View in: PubMed
    Score: 0.008
  31. Circadian susceptibility-resistance cycles to radiation and their manipulability by methylene blue. Pharmacol Ther. 1988; 39(1-3):397-402.
    View in: PubMed
    Score: 0.008
  32. Circadian pattern of continuous FUDR infusion reduces toxicities. Prog Clin Biol Res. 1987; 227B:357-73.
    View in: PubMed
    Score: 0.007
  33. Cancer chronomics III. Chronomics for cancer, aging, melatonin and experimental therapeutics researchers. J Exp Ther Oncol. 2006; 6(1):73-84.
    View in: PubMed
    Score: 0.007
  34. Circadian timing of cancer chemotherapy. Science. 1985 Apr 05; 228(4695):73-5.
    View in: PubMed
    Score: 0.007
  35. Modifying intracellular redox balance: an approach to improving therapeutic index. Lancet. 1985 Mar 09; 1(8428):565-7.
    View in: PubMed
    Score: 0.007
  36. Creation of a stable mammary tumor cell line that maintains fertility-cycle tumor biology of the parent tumor. In Vitro Cell Dev Biol Anim. 2004 Jul-Aug; 40(7):187-95.
    View in: PubMed
    Score: 0.006
  37. The clinical application of chronobiology to oncology. Am J Anat. 1983 Dec; 168(4):519-42.
    View in: PubMed
    Score: 0.006
  38. Circadian time dependence of cisplatin urinary kinetics. Clin Pharmacol Ther. 1982 Sep; 32(3):330-9.
    View in: PubMed
    Score: 0.005
  39. Cisplatin-incorporated polymeric micelles eliminate nephrotoxicity, while maintaining antitumor activity. Jpn J Cancer Res. 2001 Mar; 92(3):328-36.
    View in: PubMed
    Score: 0.005
  40. Circadian organization of thymidylate synthase activity in normal tissues: a possible basis for 5-fluorouracil chronotherapeutic advantage. Int J Cancer. 2000 Nov 01; 88(3):479-85.
    View in: PubMed
    Score: 0.005
  41. Distinct circadian time structures characterize myeloid and erythroid progenitor and multipotential cell clonogenicity as well as marrow precursor proliferation dynamics. Exp Hematol. 1998 Jun; 26(6):523-33.
    View in: PubMed
    Score: 0.004
  42. Current status of the therapy of advanced renal carcinoma. J Surg Oncol. 1977; 9(3):277-88.
    View in: PubMed
    Score: 0.004
  43. Irreversible inactivation of interleukin 2 in a pump-based delivery environment. Proc Natl Acad Sci U S A. 1996 May 28; 93(11):5460-5.
    View in: PubMed
    Score: 0.004
  44. Evaluation of chemotherapeutic agents in a new murine renal carcinoma model. J Natl Cancer Inst. 1974 Apr; 52(4):1117-22.
    View in: PubMed
    Score: 0.003
  45. Investigation of a new renal tumor model. J Surg Res. 1973 Nov; 15(5):327-36.
    View in: PubMed
    Score: 0.003
  46. A murine renal cell carcinoma. J Natl Cancer Inst. 1973 Apr; 50(4):1013-25.
    View in: PubMed
    Score: 0.003
  47. Time-varying effects in mice and rats of several synthetic ACTH preparations. Chronobiologia. 1980 Apr-Jun; 7(2):211-26.
    View in: PubMed
    Score: 0.001
  48. Synthetic adrenocorticotropin for optimizing murine circadian chronotolerance for adriamycin. Chronobiologia. 1980 Apr-Jun; 7(2):227-44.
    View in: PubMed
    Score: 0.001
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.